Nicholas S. Kirkby
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology 23
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 7
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects 28
-
- Antiplatelet Therapy and Cardiovascular Diseases 21
- Cancer Research top 10%
-
- Nitric Oxide and Endothelin Effects 14
-
- Pulmonary Hypertension Research and Treatments 9
-
- Angiogenesis and VEGF in Cancer 7
-
- Platelet Disorders and Treatments 6
- Co-authors
- Jane A. MitchellTimothy D. WarnerMelissa V. ChanBlerina Ahmetaj‐ShalaPaul C. ArmstrongPatrick W. F. HadokeDavid J. WebbAlan Bagnall
- Partner nations
- United KingdomUnited StatesQatar
In The Last Decade
Nicholas S. Kirkby
70 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 124
- Biochemistry 420
- Internal Medicine 170
- Pharmacology 546
- Cardiology and Cardiovascular Medicine 714
- Cancer Research 305
Countries citing papers authored by Nicholas S. Kirkby
This map shows the geographic impact of Nicholas S. Kirkby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas S. Kirkby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas S. Kirkby more than expected).
Fields of papers citing papers by Nicholas S. Kirkby
This network shows the impact of papers produced by Nicholas S. Kirkby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas S. Kirkby. The network helps show where Nicholas S. Kirkby may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nicholas S. Kirkby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 30 | |
| 6 | 2022 | 9 | |
| 7 | 2021 | 15 | |
| 8 | 2021 | 9 | |
| 9 | 2020 | 20 | |
| 10 | 2020 | 6 | |
| 11 | 2018 | 154 | |
| 12 | Abstract 16362: The Right Heart is Specifically Targeted by Intravenous Administration of Treprostinil: Implications for Our Understanding of How Prostacyclin Drugs Work to Treat Pulmonary Arterial Hypertension | 2018 | 1 |
| 13 | Abstract 18520: Novel Tissue-specific Cyclooxygenase-1 Knockout Mice Demonstrate a Dominant Role for Endothelial Cyclooxygenase-1 in Prostacyclin Production | 2017 | 1 |
| 14 | 2017 | 23 | |
| 15 | 2015 | 24 | |
| 16 | 2014 | 49 | |
| 17 | 2013 | 44 | |
| 18 | 2011 | 28 | |
| 19 | 2011 | 14 | |
| 20 | 2007 | 141 |
About Nicholas S. Kirkby
Nicholas S. Kirkby is a scholar working on Biochemistry, Internal Medicine and Pharmacology, having authored 72 papers that have together received 2.4k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (28 papers), Eicosanoids and Hypertension Pharmacology (23 papers), Antiplatelet Therapy and Cardiovascular Diseases (21 papers), Nitric Oxide and Endothelin Effects (14 papers), Pulmonary Hypertension Research and Treatments (9 papers), Angiogenesis and VEGF in Cancer (7 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Platelet Disorders and Treatments (6 papers). The work is most often cited by research in Biochemistry (420 citations), Internal Medicine (170 citations) and Pharmacology (546 citations). Nicholas S. Kirkby has collaborated with scholars based in United Kingdom, United States and Qatar. Frequent co-authors include Jane A. Mitchell, Timothy D. Warner, Melissa V. Chan, Blerina Ahmetaj‐Shala, Paul C. Armstrong, Patrick W. F. Hadoke, David J. Webb, Alan Bagnall, Martina H. Lundberg and William R. H. Wright. Their work appears in journals such as The FASEB Journal, PLoS ONE, Circulation, British Journal of Pharmacology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.